125 related articles for article (PubMed ID: 1652328)
1. Rapid detection of CMV reactivation after BMT by CMV-IEA expression in granulocytes.
Boland GJ; Vlieger A; de Gast GC; Zwaan FE; Verdonck LF; de Weger RA; Jiwa NM
Bone Marrow Transplant; 1991; 7 Suppl 2():42. PubMed ID: 1652328
[No Abstract] [Full Text] [Related]
2. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
[TBL] [Abstract][Full Text] [Related]
3. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
[TBL] [Abstract][Full Text] [Related]
4. CMV antigenemia as diagnostic tool for diagnosing active cytomegalovirus infection.
van Son WJ; van den Berg AP; The TH
Bone Marrow Transplant; 1991; 7 Suppl 2():45. PubMed ID: 1652331
[No Abstract] [Full Text] [Related]
5. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
[No Abstract] [Full Text] [Related]
6. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
[TBL] [Abstract][Full Text] [Related]
7. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
[TBL] [Abstract][Full Text] [Related]
9. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antigenemia assay and screening bronchoscopy for detection of cytomegalovirus infection after bone marrow transplantation.
Machida U; Kami M; Kanda Y; Mori S; Ohashi K; Tanikawa S; Akiyama H; Sakamaki H
Bone Marrow Transplant; 1999 Nov; 24(10):1153-4. PubMed ID: 10578168
[No Abstract] [Full Text] [Related]
12. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
[TBL] [Abstract][Full Text] [Related]
13. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid.
Goto H; Yuasa K; Sakamaki H; Nakata K; Komuro I; Iguchi M; Okamura T; Ieki R; Tanikawa S; Akiyama H; Onozawa Y; Mochida Y
Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation.
Humar A; O'Rourke K; Lipton J; Messner H; Meharchand J; Mahony J; Walker I; Wasi P; McGeer A; Moussa G; Chua R; Mazzulli T
Bone Marrow Transplant; 1999 Jan; 23(1):45-51. PubMed ID: 10037050
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegaloviral infection in patients with hemoblastoses].
Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection presenting as polyarticular arthritis following autologous BMT.
Burns LJ; Gingrich RD
Bone Marrow Transplant; 1993 Jan; 11(1):77-9. PubMed ID: 8381695
[TBL] [Abstract][Full Text] [Related]
19. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
[TBL] [Abstract][Full Text] [Related]
20. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]